Next Quarterly Earnings
Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
UroGen Pharma
UroGen Pharma is a US-based biotechnology company specializing in the development of innovative therapies for urological cancers. Through its proprietary RTGel technology, UroGen enables new, minimally invasive treatment approaches for patients suffering from urothelial carcinomas.
Frequently asked questions
When will UroGen Pharma report its next quarterly earnings?
UroGen Pharma is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did UroGen Pharma last report quarterly earnings?
UroGen Pharma last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.28 USD.
How often has UroGen Pharma beaten expectations?
UroGen Pharma has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
How do I add the UroGen Pharma earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
1/5
Quarters above estimates
20%
Beat rate
-2.2%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
UroGen Pharma
Country
🇺🇸
More Financial Information